Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Align Technology reported robust financial performance for the fourth quarter and full year 2025, with revenues and margins surpassing expectations.</li><li>The company achieved a record $1.048 billion in quarterly revenues and $4 billion in annual revenues, driven by strong demand for its Clear Aligner systems.</li><li>Clear Aligner volumes reached record levels with 677,000 cases in Q4, a 7.7% year-over-year increase, contributing to annual Clear Aligner revenues of $3.2 billion and volumes of 2.6 million cases.</li></ul>

Align Technology reported robust financial performance for the fourth quarter and full year 2025, with revenues and margins surpassing expectations.The company achieved a record $1.048 billion in quarterly revenues and $4 billion in annual revenues, driven by strong demand for its Clear Aligner systems.Clear Aligner volumes reached record levels with 677,000 cases in Q4, a 7.7% year-over-year increase, contributing to annual Clear Aligner revenues of $3.2 billion and volumes of 2.6 million cases.

Align Technology: No-Refinement Aligners—A Breakthrough Product or a Strategic Revenue Unlock?

<ul><li>Align Technology presented their third-quarter results for 2025, highlighting a mixed performance across its various business segments.</li><li>Overall, revenues were posted at $996 million, reflecting a slight sequential decrease of 1.7% but a year-over-year increase of 1.8%.</li><li>This reflects modest growth driven primarily by the Clear Aligners segment.</li></ul>

Align Technology presented their third-quarter results for 2025, highlighting a mixed performance across its various business segments.Overall, revenues were posted at $996 million, reflecting a slight sequential decrease of 1.7% but a year-over-year increase of 1.8%.This reflects modest growth driven primarily by the Clear Aligners segment.

Align Technology Uncovered: What’s Fueling Its Massive EMEA & APAC Momentum?

External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

External reports (aggregated public sources)

Value Investors Club

Key points (machine generated)<ul><li>Align Technology Inc. (ALGN) is poised for a resurgence with a favorable reward/risk ratio post-Covid.</li><li>The company primarily operates through its Clear Aligner segment, with Invisalign accounting for 81% of operating profit.</li><li>Invisalign's competitive edge includes efficiency, superior technology, and a strong market presence, particularly in the Americas.</li></ul>This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Key points (machine generated)Align Technology Inc. (ALGN) is poised for a resurgence with a favorable reward/risk ratio post-Covid.The company primarily operates through its Clear Aligner segment, with Invisalign accounting for 81% of operating profit.Invisalign's competitive edge includes efficiency, superior technology, and a strong market presence, particularly in the Americas.This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Align Technology Inc (ALGN) - Wednesday, Jul 30, 2025

Equity Long-Short Analyst

Pyari Menon

Thematic (Sector/Industry)

<ul>
<li>This report is almost entirely based on datamined from technical publications related to patents and innovations in the area of Odontology.</li>
<li>The industry will see significant consolidation as mid-sized and smaller players with inspired innovations are be bought out as the industry seeks more cost-efficient distribution channels</li>
<li>Among the listed companies <a href="https://www.smartkarma.com/entities/3-m-co" target="_blank" data-smartkarma-citation="entities:14866:1" rel="noopener">3M Co (MMM US)</a> , <a href="https://www.smartkarma.com/entities/dentsply-international-inc" target="_blank" data-smartkarma-citation="entities:10926:1" rel="noopener">Dentsply International (XRAY US)</a> , <a href="https://www.smartkarma.com/entities/align-technology-inc" target="_blank" data-smartkarma-citation="entities:2817:1" rel="noopener">Align Technology (ALGN US)</a> , <a href="https://www.smartkarma.com/entities/envista-holdings-corp" target="_blank" data-smartkarma-citation="entities:35866:1" rel="noopener">Envista Holdings (NVST US)</a>  &amp; <a href="https://www.smartkarma.com/entities/straumann-holding-ag" target="_blank" data-smartkarma-citation="entities:22493:1" rel="noopener">Straumann Holding (STMN SW)</a> stand out. </li>
</ul>


This report is almost entirely based on datamined from technical publications related to patents and innovations in the area of Odontology.
The industry will see significant consolidation as mid-sized and smaller players with inspired innovations are be bought out as the industry seeks more cost-efficient distribution channels
Among the listed companies 3M Co (MMM US) , Dentsply International (XRAY US) , Align Technology (ALGN US) , Envista Holdings (NVST US)  &amp; Straumann Holding (STMN SW) stand out. 


A Detailed Look Into Innovations in Dentistry

High Quality Stock Setups, Weekly Stock Bull Finder

Weekly Stock Bull Finder

High Quality Stock Setups

Finding high potential stock setups on quality companies

<ul><li>After witnessing a parabolic advance at the beginning of the Federal Reserve’s tightening cycle in early 2022, the US dollar has decisely break down below prior weekly support levels in a large bearish engulfing candle last week.</li><li>This breakdown can serve as a tailwind for multi-nationals (especially technology names), commodities, emerging markets, treasuries, and cryptos.</li><li>The dollar is now sitting at a 15 month low. This decline may not be over as the MACD indicator is now crossing down.</li></ul>

After witnessing a parabolic advance at the beginning of the Federal Reserve’s tightening cycle in early 2022, the US dollar has decisely break down below prior weekly support levels in a large bearish engulfing candle last week.This breakdown can serve as a tailwind for multi-nationals (especially technology names), commodities, emerging markets, treasuries, and cryptos.The dollar is now sitting at a 15 month low. This decline may not be over as the MACD indicator is now crossing down.

United States

Align Technology, Inc. designs, manufactures, and markets the Invisalign System, a method for treating the misalignment of teeth.  The Company's system corrects the misalignment using a series of clear, removable appliances that move teeth to a desired final position.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Align Technology (ALGN US)

Align Technology: No-Refinement Aligners—A Breakthrough Product or a Strategic Revenue Unlock?

Align Technology reported robust financial performance for the fourth quarter and full year 2025, with revenues and margins surpassing...

Baptista Research

Align Technology Uncovered: What’s Fueling Its Massive EMEA & APAC Momentum?

Align Technology presented their third-quarter results for 2025, highlighting a mixed performance across its various business segments. Overall,...

Baptista Research

Align Technology Inc (ALGN) - Wednesday, Jul 30, 2025

Align Technology Inc. (ALGN) is poised for a comeback with strong Invisalign sales, a favorable valuation, and promising growth potential following...

Value Investors Club (VIC)

A Detailed Look Into Innovations in Dentistry

The report highlights the most innovative well-known & lesser-known dental companies driving advancements in digital dentistry, materials,...

Pyari Menon

Weekly Stock Bullfinder - Week of 7/17

After witnessing a parabolic advance at the beginning of the Federal Reserve’s tightening cycle in early 2022, the US dollar has decisely break...

Weekly Stock Bull Finder

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)